Three new podocarpane diterpenoids, namely anemhupehins A-C (1-3), together with four known analogues (4-7), have been isolated from aerial parts of Anemone hupehensis. Their structures were characterized based on extensive spectroscopic data. Compounds 1 and 4 showed certain cytotoxicities against human cancer cell lines. 
Introduction
Podocarpane diterpenoids usually possessed a backbone of seventeen carbons arranged in a tricyclohexane system close to abietane and pimarane [1] [2] [3] [4] [5] [6] [7] [8] . They do not occur extensively in nature but are present in several genera, such as Azadirachta [1] [2] [3] [4] [5] , Humirianthera [6] , Micrandropsis [7] , and Podocarpus [8] . Previous studies have disclosed a few biologically active podocarpane molecules, such as 13-hydroxy-8,11,13-podocarpatriene-19-oic acid, a highly fungistatic agent [9, 10] , and 7-oxo-13-hydroxy-14-amino-8,11,13-podocarpatriene, a potent 5-lipoxygenase inhibitor [11] .
Anemone hupehensis is a flowering herbaceous perennial in the Ranunculaceae family. It is about one meter high and native in central China. In previous chemical studies on this plant, a few triterpenoids and their saponins were reported [12] [13] [14] [15] . In our continuous searching for new and bioactive natural products, we investigated the chemical constituents in aerial parts of A. hupehensis, which resulted . These data elucidated the structure of 1 to be 6,13-dihydroxy-8,11,13-podocarpatriene. An ROESY experiment revealed the relative configuration of 1 (Fig. 2) , in which the cross peak of H-19/H-20 indicated that CH 3 -19 and CH 3 -20 were in the same side (b orientation), while the cross peaks of H-18/H-5, H-5/H-6, and H-6/H-18 indicated that H-6 should be a oriented. As established by the ROESY data, the energy minimized 3D structure of 1 revealed stereoconfiguration of 1. A Newman projection of C-5 and C-6 indicated the dihedral angle between H-5 and H-6 to be close to h = 90° (Fig. 2) , which resulted in the coupling constants of J 5,6 = 0 Hz, that is why H-5 presented as a singlet in the 1 H NMR spectrum. All these data elucidated the structure of 1 to be 6b,13-dihydroxy-8,11,13-podocarpatriene, named anemhupehin A.
Compound 2 was isolated as a colorless oil. The HRE-SIMS established the molecular formula to be C 17 (Table 1) . These data showed similar patterns to those of 1. rather than at C-6 in 1. Detailed analyses of 2D NMR data indicated that the other parts of 2 were the same to those of 1. In the ROESY spectrum, cross peaks of H-5/H-7 suggested that OH-7 should be b oriented. Therefore, compound 2 was elucidated as 7b,13-dihydroxy-8,11,13-podocarpatriene, named anemhupehin B.
Compound 3 was initially isolated as a mixture with 2. A further isolation of this mixture only obtained pure compound 2, while the amount of compound 3 is too less to obtain the clear NMR spectra. However, careful analyses of MS data of 3 and NMR spectra of the mixture (see Supporting Information), with the aid of NMR spectrum of 2, can unambiguously elucidate the structure of 3. The 2 , the same to that of 2. The 13 C NMR data also showed good agreements with those of 2. Analyses of 1D and 2D NMR data suggested that compound 3 should have the same planar structure to that of 1. However, the 13 C NMR shift of C-7 at d C 68.4 in 3 was significantly different from that in 2, indicating that compound 3 might be an epimer of 2. In the ROESY spectrum of the mixture, the cross peaks of 19/H-20 and H-18/H-5 suggested that C-5 and C-10 possessed the same configurations to those in compounds 2. Therefore, compound 3 was determined to be 7-epimer of 2. The 3D structure analyses of 3 and 2 also supported that OH-7 in 3 should be a oriented. Therefore, compound 3 was elucidated as 7a,13-dihydroxy-8,11,13-podocarpatriene, named anemhupehin C.
Four known analogues were identified as 13,14-dihydroxy-8,11,13-podocarpatriene (4) [16] , 13-hydroxy-8,11,13-podocarpatriene (5) [17] , 13,14-dihydroxy-7-oxo-8,11,13-podocarpatriene (6) [17] , and 13-hydroxy-7-oxo-8,11,13-podocarpatriene (7) [18] . Compound 4 was isolated as a natural product for the first time.
Compounds 1 and 4-7 were evaluated for their cytotoxicities to five human cancer cell lines. As a result, compounds 1 and 4 showed moderate activities as shown in Table 2 . The other compounds were inactive to cancer cell lines (IC 50 [ 40 lM).
Experimental

General Experimental Procedures
Optical rotations were measured on a Jasco-P-1020 polarimeter. IR spectra were obtained using a Bruker Tensor 27 FT-IR spectrometer with KBr pellets. NMR spectra were acquired with a Bruker DRX-600 with tetramethylsilane (TMS) used as an internal standard. HRESIMS were recorded on an API QSTAR Pulsar spectrometer. Silica gel (200-300 mesh), Sephadex LH-20 and RP-18 gel (20-45 lm) were used for column chromatography (CC). Medium pressure liquid chromatography (MPLC) was performed on a Biotage system. Preparative high performance liquid chromatography (prep-HPLC) was performed on an Agilent 1260 liquid chromatography system equipped with Zorbax SB-C18 columns (5 lm, 9.4 mm 9 150 mm or 21.2 mm 9 150 mm) and a DAD detector. Fractions were monitored by TLC and spots were visualized by heating silica gel plates immersed in H 2 SO 4 in EtOH, in combination with the Agilent 1200 series HPLC system (Eclipse XDB-C18 column, 5 lm, 4.6 9 150 mm).
Plant Material
Aerial parts of A. hupehensis were collected from ShenLongJia of Hubei province, central China in September 2016 and identified by Prof. Ming-Qing Pan of Wuhan University. A specimen (No. COP-HF20160912.4) was deposited at South-Central University for Nationalities.
Extraction and Isolation
The air dried sample of A. hupehensis (8 kg) were extracted with methanol (24 h 9 3) to afford an extract. The extract was partitioned with water and EtOAc (1:1). The extract of EtOAc lay (202 g) was subjected to silica gel CC using CHCl 3 -MeOH (from 1:0 to 0:1) to give eight fractions (A-H). Fraction C (23.8 g) was separated by MPLC with gradient mixture of MeOH and H 2 O (20:80-100:0, v/v) to afford ten sub-fractions (C1-C10). Fraction C2 (500 mg) was isolated by silica gel CC using petroleum ether/Me 2 CO (6:1) to afford several subfractions, and compound 6 (13 mg) crystallized from one subfraction. Fraction C4 (280 mg) was purified by Sephadex LH-20 (MeOH) to give compounds 1 (7.2 mg) and 4 (8.6 mg). Compounds 2 and 3 was initially isolated as a mixture (2.8 mg) as obtained from fraction C5 (120 mg) by silica gel CC, and was re-purified by HPLC (MeCN:H 2 O (v/v) from 2:8 to 4:6 in 25 min) to afford pure compounds 2 (1.1 mg) and 3 (less than 0.5 mg). Fraction C6 (300 mg) was isolated by Sephadex LH-20 (MeOH) and then purified by HPLC (MeCN:H 2 O (v/v) from 3:7 to 4:6 in 25 min) to afford 5 (6.8 mg) and 7 (3.4 mg).
Anemhupehin A (1)
Colorless oil, a ½ 
Cytotoxicity Assay
Human myeloid leukemia HL-60, hepatocellular carcinoma SMMC-7721, lung cancer A-549 cells, breast cancer MCF-7 and colon cancer SW480 cell lines were used in the cytoxic assay. All cell lines were cultured in RPMI-1640 or DMEM medium (Hyclone, USA), supplemented with 10% fetal bovine serum (Hyclone, USA) in 5% CO 2 at 37°C. The cytotoxicity assay was performed according to the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) method in 96-well microplates [19] . Cisplatin was used as a positive control.
